CCC
XYL icon

Crescent Capital Consulting’s Xylem XYL Stock Holding History

Crescent Capital Consulting’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$60K Buy
500
+200
+67% +$24.8K 0.01% 281
2021
Q3 		$37K Hold
300
– – 0.01% 335
2021
Q2 		$36K Hold
300
– – 0.01% 300
2021
Q1 		$32K Hold
300
– – 0.01% 316
2020
Q4 		$31K Buy
+300
New +$28.2K 0.01% 286

Other funds holding XYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Crescent Capital Consulting's XYL Position: Q4 2021 in Review

Crescent Capital Consulting increased its Xylem (XYL) stake by 67% in Q4 2021, buying an estimated $24.8K and bringing the position to 500 shares worth $60K. The position accounts for 0.01% of the portfolio, ranked #281.

Crescent Capital Consulting first reported a position in XYL in Q4 2020 and has held it in 5 quarters since. 827 funds tracked by Wall St. Rank hold XYL as of Q4 2021.

  • Crescent Capital Consulting held 500 shares of Xylem worth $60K as of Q4 2021.
  • Crescent Capital Consulting bought 200 Xylem shares in Q4 2021, an estimated $24.8K.
  • Xylem made up 0.01% of Crescent Capital Consulting's portfolio in Q4 2021, its #281 holding.
  • Crescent Capital Consulting first reported a position in Xylem in Q4 2020 and has held it in 5 quarters since.
  • 827 funds tracked by Wall St. Rank held Xylem as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.